ALKUM COUGH EXPECTORANT

This brand name is authorized in Nigeria.

Active ingredients

The drug ALKUM COUGH EXPECTORANT contains a combination of these active pharmaceutical ingredients (APIs):

1	Cetirizine UNII 64O047KTOA - CETIRIZINE HYDROCHLORIDE
	Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than Η1-receptors.
	Read more about Cetirizine
2	Ammonium chloride UNII 01Q9PC255D - AMMONIUM CHLORIDE
	Read more about Ammonium chloride
3	Menthol UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
	Read more about Menthol
4	Sodium citrate UNII 1Q73Q2JULR - SODIUM CITRATE, UNSPECIFIED FORM
	Sodium citrate has no relevant pharmacodynamic activity other than that caused by its alkalinity (e.g. its gastric acid neutralising capacity). Sodium citrate is a non-particulate antacid for use by mouth to prior to general anaesthesia for caesarean section.
	Read more about Sodium citrate

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-4057	Syrup	ALKUM COUGH EXPECTORANT(NON DROWSY) SYRUP 2.5 mg/5 mL; 100 mg/5 mL; 40 mg/5 mL; 2 mg/5 mL 100ml	11 RNW-PP-229127 ALKUM COUGH EXPECTORANT(NON DROWSY) CETIRIZINE HCL 2.5MG; AMMONIUM CHLORIDE 100MG; MENTHOL 2MG; SODIUM CITRATE 40MG/5ML CETIRIZINE HCL 2.5MG; AMMONIUM CHLORIDE 100MG; MENTHOL 2MG; SODIUM CITRATE 40MG/5ML; PROPYL PARABEN; CITRIC ACID; SORBITOL; GLYCERIN; SUCROSE; CARBOXYMETHYLCELLULOSE SODIUM; METHYL PARABEN; NEELICOL GRASS COLOUR. B4-4057 Drugs Nigerian Products 100ML OTC 12/9/2022 ALBEN HEALTH CARE INDUSTRIES LTD., ONITSHA AWKA ROAD, OGIDI ANAMBRA 8033332325 albenng@rocketmail.com Alben Healthcare Industries Limited, KM 15 Old Onitsha Awka Road ,Ogidi, Anambra State, Nigeria., Nigeria	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R05CA10	Combinations	R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CA Expectorants
Discover more medicines within R05CA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-4057